European Commission Grants Marketing Authorization For Merck’s Ebola Vaccine

STAT: Ebola vaccine approved in Europe in landmark moment in fight against a deadly disease
“…The European Commission granted marketing authorization to Merck’s vaccine, known as Ervebo, on Monday, less than a month after the European Medicines Agency recommended it be licensed. It is currently being used in the Democratic Republic of the Congo under a ‘compassionate use’ or research protocol similar to a clinical trial…” (Branswell, 11/11).

Additional coverage of the vaccine’s European approval is available from CIDRAP News, Forbes, The Hill, and Reuters.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.